EXHIBIT 99.1



[DJ ORTHO LOGO]


COMPANY INVESTOR/ MEDIA CONTACT:
dj Orthopedics, Inc.
Mark Francois
Director of Investor Relations
(760) 734-4766
www.djortho.com

FOR IMMEDIATE RELEASE


                 DJ ORTHOPEDICS TO BENEFIT FROM CONSOLIDATION OF
               MANUFACTURING OPERATIONS TO ITS MEXICAN FACILITIES

SAN DIEGO CALIF., (SEPTEMBER 4, 2002) -- dj Orthopedics Inc. (NYSE: DJO), a
designer, manufacturer and marketer of products and services for the orthopedic
sports medicine market, today announced its plan to relocate the manufacturing
of all remaining soft bracing goods and certain non-custom rigid bracing
products from Vista, California to its manufacturing facilities located in
Tijuana, Mexico. The action is part of a broader corporate performance
improvement program announced by the Company on August 1, 2002, to streamline
operations and reduce manufacturing costs and operating expenses. In connection
with this move, the Company anticipates a work force reduction of up to 250
employees over a transition period of several months. The Company anticipates a
similar increase in employees in its Mexican operations.

"We are committed to an overall performance improvement program to strengthen
the Company's competitive edge through more efficient operations and an improved
overall cost structure," said Les Cross, president and chief executive officer
of dj Orthopedics. "The Company has become highly adept in its manufacturing
capabilities in Mexico and this relocation, a component of our operating
initiatives to improve productivity and inventory management, will enable the
company to realize significant cost savings for several product lines."

Although the Company expects to achieve substantial cost savings from the
manufacturing consolidation announced today, the Company has not yet determined
the total savings it expects to generate from its broader corporate performance
improvement program, or the related costs to implement the program.

                                     -more-



                                       1


The Company began its manufacturing operations in Mexico in 1994, and in 2001,
consolidated two separate Mexican manufacturing operations into a more
efficient, single campus location. During the first quarter of 2002, the Company
successfully consolidated much of its soft goods sewing operations to this
Mexican campus. The Company's Mexican operation was recently honored with a
prestigious Top-25 finish in Industry Week's "200 Best Plants Award" in North
America.

dj Orthopedics is a global orthopedic sports medicine company specializing in
the design, manufacture and marketing of surgical and non-surgical products and
services that repair, regenerate and rehabilitate soft tissue and bone, help
protect against injury, and treat osteoarthritis of the knee. Its broad range of
over 600 existing products, many of which are based on proprietary technologies,
includes rigid knee braces, soft goods, specialty and other complementary
orthopedic products and its recently introduced line of surgical products. These
products provide solutions for patients and orthopedic sports medicine
professionals throughout the patient's continuum of care.

This press release contains or may contain forward-looking statements such as
statements regarding the Company's future growth and profitability, growth
strategy and trends in the industry in which the Company operates. These
forward-looking statements are based on the Company's current expectations and
are subject to a number of risks, uncertainties and assumptions. Among the
important factors that could cause actual results to differ significantly from
those expressed or implied by such forward-looking statements are the risk that
we may not be able to successfully implement our business strategy or our
performance improvement program; our limited experience in designing,
manufacturing and marketing products for the repair and regeneration segments of
the orthopedic sports medicine market; our transition to direct distribution of
our products in certain foreign countries; our ability to successfully develop
or license and timely introduce and market new products or product enhancements;
our dependence on our orthopedic professionals, agents and distributors for
marketing our products; risks associated with our acquisition strategy and
international operations; competition in our markets; the risk that our
quarterly operating results are subject to substantial fluctuations; our high
level of indebtedness and the restrictions imposed by the terms of our
indebtedness; our ability to generate cash to service our debts; the effects of
healthcare reform, managed care and buying groups on prices of our products; the
uncertainty of domestic and foreign regulatory clearance and approval of our
products; the sensitivity of our business to general economic conditions;
uncertainty relating to third party reimbursement; pending litigation; and the
other risk factors affecting the Company detailed from time to time in the
documents filed by the Company with the Securities and Exchange Commission.

                                      # # #



                                       2